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ABSTRACT 
A hybrid allele between the carboxyl ester lipase gene (CEL) and its pseudogene, CELP 
(called CEL–HYB), generated by non-allelic homologous recombination between CEL intron 
10 and CELP intron 10′, was found to increase susceptibility to chronic pancreatitis in a case–
control study of patients of European ancestry. We attempted to replicate this finding in 3 
independent cohorts from China, Japan, and India, but failed to detect the CEL–HYB allele in 
any of these populations. The CEL–HYB allele might therefore be an ethnic-specific risk 
factor for chronic pancreatitis. An alternative hybrid allele (CEL–HYB2) was identified in all 
3 Asian populations (1.7% combined carrier frequency), but was not associated with chronic 
pancreatitis. 
 
Keywords: Disease Susceptibility; Human Genetics; Nonsense-Mediated mRNA Decay; 
Pancreatic Acinar Cells.  
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The etiology of chronic pancreatitis (CP) is complex and involves a subtle interplay between 
genetic and environmental factors. Most of the hitherto reported genes/loci affecting disease 
susceptibility encode proteins of the protease-antiprotease system of the pancreatic acinar 
cells.1-7 A hybrid allele (CEL–HYB), involving the CEL gene (encoding pancreatic carboxyl 
ester lipase8) and its tandemly linked pseudogene (CELP), was recently reported to be 
significantly overrepresented in CP cases as compared with controls, firstly in a discovery 
cohort of patients with familial CP and then in three replication cohorts of patients with 
idiopathic CP.9 The CEL–HYB allele resulted from non-allelic homologous recombination 
(NAHR) occurring between CEL intron 10 and CELP intron 10′; replacement of the eleventh 
and last exon of CEL by CELP exon 11′ would yield a premature stop codon within the third 
“pseudo” 33-bp variable number tandem repeat (VNTR)9 (Figure 1A). The mutant enzyme is 
more stable than its wild-type (WT) counterpart and induced autophagy in cellular models,9 
suggesting a novel pathogenic mechanism. However, since the patients analyzed in the 
original study9 were solely of European ancestry, replication in independent populations of 
different ethnicity was warranted.10  
The detection of the CEL–HYB allele is dependent upon a long-range duplex PCR 
assay.9 Using French CEL–HYB positive samples, we found that the originally described 
PCR assay9 yielded better results under slightly modified conditions (see Supplementary 
Material and Supplementary Figure 1). Consequently, these modified conditions were 
employed to screen for the CEL–HYB allele in three Asian populations. We first analyzed a 
cohort of Han Chinese patients with idiopathic CP. The previously described CEL–HYB-
specific 3.2-kb band was detected in 2.4% (19/799) of patients and 1.9% (20/1028) of controls 
(P = 0.64; Table 1). Sequencing of the 3.2-kb band-containing PCR products however 
revealed that none of these Chinese CEL–HYB alleles corresponded to that expected; instead, 
they invariably resulted from an NAHR event occurring within a 239-bp sequence tract 
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affecting the intron 9/exon 10 boundary of CEL and the intron 9′/exon 10′ boundary of CELP 
(Supplementary Figure 2). Hereafter, we term the previously reported disease-associated 
CEL–HYB allele9 as CEL–HYB1 so as to distinguish it from this newly described allele, 
CEL–HYB2. 
Closer inspection of the 39 Chinese CEL–HYB2 alleles revealed that they could be 
divided into two subtypes by reference to three single nucleotide polymorphisms (SNPs) 
present within the substituting CELP sequence (Supplementary Figure 2); 38 harbored the G 
allele of rs10901232A/G, the T allele of rs10901233C/T and the G allele of rs671412A/G 
(termed CEL–HYB2a), the sole exception harboring the alternative alleles of these three 
SNPs (termed CEL–HYB2b). We further genotyped two idiopathic CP cohorts from Japan 
and India. Results from the Japanese cohort were remarkably similar to those from the 
Chinese cohort whereas in the Indian cohort, only one control carried a CEL–HYB allele, and 
this corresponded to CEL–HYB2b (Table 1). Note that a variant similar to CEL–HYB2 was 
mentioned in passing by Fjeld et al.9 to be present in one European case and four controls, 
although no sequence details were presented. Sequencing of two corresponding French CEL–
HYB positive samples revealed their identity to be CEL–HYB2b. In short, the PCR assay 
employed efficiently detects all three CEL hybrid alleles, the differentiation of which relies 
upon the sequencing of the respective PCR products.  
Both CEL–HYB2a and CEL–HYB2b variants harbor premature stop codons within their 
chimeric exons 10 (Figure 1A); their corresponding mRNAs could therefore be subject to 
significant degradation by nonsense-mediated mRNA decay (NMD). However, this might not 
be the case for CEL–HYB1 because mRNAs that harbor a stop codon in the final exon 
usually escape degradation by NMD.11 To explore this possibility, we first sought to compare 
the mRNA expression levels of CEL–HYB2a versus CEL–HYB1 in vitro (Supplementary 
Material and Supplementary Tables 1 and 2). Briefly, we PCR amplified the full-length 
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genomic CEL–HYB2a and CEL–HYB1 sequences from their corresponding carriers and 
cloned the resulting PCR products into the pcDNA3.1/V5-His-TOPO vector. Reverse 
transcription-PCR (RT-PCR) analyses of mRNAs from subsequently transfected HEK293T 
cells indicated lower CEL–HYB2a mRNA expression as compared to CEL–HYB1 (Figure 
1B). Further quantitative RT-PCR analyses demonstrated that the mRNA expression of CEL–
HYB2a accounted for only 60% of that of CEL–HYB1 (Figure 1C). Then, we tested whether 
the mRNA expression level of CEL–HYB2a could be increased by treatment of the 
transfected cells with cycloheximide, a known NMD inhibitor12 and found this to be the case 
(Figure 1D). Hence, we conclude that mRNA expression from the CEL–HYB2a allele is 
significantly reduced by NMD. This conclusion probably also applies to CEL–HYB2b owing 
to its high sequence similarity with CEL–HYB2a (Figure 1A).  
In summary, contrary to our expectation, we failed to identify the CEL–HYB1 allele in 
any of the three Asian cohorts. Based on the allele frequency of CEL–HYB1 in healthy 
German and French populations (0.4%),9 the power to detect at least one CEL–HYB1 carrier 
among the cases is estimated to be >86%, even for the smallest cohort. Given that most rare 
variants (defined as a minor allele frequency of <0.5%) are population-specific,13 CEL–HYB1 
may be an ethnicity-specific disease risk factor, although this remains to be confirmed by 
replication in an independent cohort of European ancestry (e.g., the North American 
Pancreatitis Study 214). The other unexpected finding was the identification of an alternative 
CEL–HYB2 allele in all three Asian populations. The significant degradation of CEL–HYB2a 
mRNA by NMD and the observation that pancreatic exocrine function has been found to be 
normal in Cel-knockout mice15 are consistent with the apparent lack of any association 
between CEL–HYB2a and CP.  
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Figure Legend 
Figure 1. (A) Key differences between CEL–HYB1 (originally termed CEL–HYB9), CEL–
HYB2 and the wild-type CEL gene in terms of the defining exon 10, intron 10 and exon 11 
sequences. The gene structure of CEL (in black) and that of the replacement CELP sequences 
(in green) within CEL–HYB1 and CEL–HYB2 were described in accordance with GenBank 
accession number AF072711.1. In CEL, the VNTRs within exon 11 are indicated in purple; 
nucleotide positions of the exon 10 boundaries and the beginning of exon 11 are numbered by 
reference to the A of the translational initiation codon ATG as c.1; the translational 
termination codon is denoted by a vertical blue bar, with the last coding nucleotide and the 
amino acid position of the translational termination codon being numbered above and below 
the bar. In CEL–HYB1, CEL–HYB2a and CEL–HYB2b, the presumed premature stop 
codons are indicated in a similar manner. (B) A representative gel showing the RT-PCR 
analyses of HEK293T cells transfected with expression constructs carrying the full-length 
CEL–HYB1 and CEL–HYB2a genomic sequences. Sanger sequencing of the approximately 
2.2-kb CEL–HYB1 and CEL–HYB2a products revealed that all introns were spliced 
correctly. CV, control vector. (C) Relative mRNA expression levels of CEL–HYB2a versus 
CEL–HYB1 in vitro as determined by quantitative RT-PCR analyses. CV, control vector. (D) 
Relative mRNA expression levels of CEL–HYB2a in transfected cells with (grey) and 
without (black) cycloheximide treatment as determined by quantitative RT-PCR analyses. **, 
P < 0.01.   
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Table 1. Carrier frequencies of the CEL–HYB2 variant in Chinese, Japanese and Indian 
subjects with idiopathic chronic pancreatitis* 
Populations Case Control P valuea 
+/n % +/n % 
Chinese 19/799 2.4 20 (1)/1028 1.9 0.64 
Japanese 4b/248 1.6 7 (2)/403 1.7 0.85 
Indian 0/280 0 1 (1)/225 0.4 0.91 
Combined 23/1327 1.7 28 (4)/1656 1.7 0.96 
* Number of subjects carrying the less frequent CEL–HYB2 subtype, CEL–HYB2b, is 
indicated in parentheses wherever applicable. 
a
 Two-tailed Fisher’s exact test. 
b
 One patient is a homozygote. 
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Supplementary Material 
 
Subjects 
Chinese, Japanese and Indian patients with idiopathic chronic pancreatitis (i.e. absence of a 
positive family history and any known precipitating factor such as alcohol abuse) and healthy 
controls from their corresponding general populations were recruited by the three leading Asian 
pancreatitis groups. A clinical diagnosis of chronic pancreatitis was based on two or more of 
the following criteria: (i) presence of a typical history of recurrent pancreatitis; (ii) radiological 
findings such as pancreatic calcification and/or pancreatic irregularities revealed by endoscopic 
retrograde pancreatography or by magnetic resonance imaging of the pancreas; and (iii) 
pathological sonographic findings. Informed consent was obtained from each patient and the 
study was approved by the respective ethics committees of the three leading Asian pancreatitis 
groups. 
 
Screening for the CEL–HYB Allele 
Screening for the disease-associated CEL–HYB allele (termed CEL–HYB1 in the present 
study) was performed in accordance with the previously reported method9 but with some 
modified reaction conditions. Specifically, we performed the PCR reactions in total volumes of 
10 μl containing 2 × GC buffer, 0.4 μM primer L11F (5'-
GTCCCTCACTCATTCTTCTATGGCAAC-3'), 0.2 μM of the primers IAR (5'-
TCCAAAGCCCTAGCAGTAACGA-3') and CELP VNTR-rev (5'-
CTGTGGAGGGCATGGAACT-3'), 0.4 mM each dNTP, 0.5 U LA Taq DNA polymerase and 
10-50 ng genomic DNA. These conditions work better than those originally described for 
genotyping the French CEL–HYB1 positive samples (Supplementary Figure 1). 
 
Sequencing the Positive Samples 
Samples showing the CEL–HYB-specific 3.2-kb band9 were subjected to Sanger 
sequencing using the previously published primers, S10F and S10R.9 Crossover regions of the 
CEL–HYB alleles were assigned by evaluating the nucleotide positions that serve to 
discriminate the CEL and CELP sequences within the region of interest. To this end, we aligned 
CEL exon 10 and its partial flanking sequences against the corresponding CELP sequences, the 
discriminant nucleotides being clearly indicated (Supplementary Figure 2). 
The assessment of significance of the differences between the carrier frequencies of the 
CEL–HYB alleles in patients and controls was performed by means of two-tailed Fisher’s exact 
test using StatCalc (2 × 2 Tables) from Epi Info™ 7 (http://wwwn.cdc.gov/epiinfo/index.htm). 
The difference was regarded as being statistically significant when the P value was ≤ 0.05.  
 
Construction of Expression Vectors for mRNA Expression Analysis in the 
Context of the Full-Length CEL–HYB1 and CEL–HYB2a Genomic 
Sequences 
We PCR amplified the full-length (approximately 10-kb) genomic CEL–HYB1 and CEL–
HYB2a sequences (going from the 5'-untranslated region of CEL to the 3'-untranslated region 
of the replacement CELP) from their corresponding carriers and cloned the resulting PCR 
products into the pcDNA3.1/V5-His-TOPO vector using previously described methods.16,17 
Specifically, the long-range PCR was performed using 50 ng DNA in a 50 μL reaction mixture 
with 2.5 U TaKaRa LA Taq DNA polymerase, 8 μL dNTP Mixture (400 µM final), 5 µL 10 × 
PCR buffer system, and 1 μM each primer of primer pair A1 (Supplementary Table 1). Thermal 
cycling conditions were: initial denaturation at 94°C for 1 min, followed by 30 cycles of 
denaturation at 98°C for 10 s, annealing and extension at 68°C for 12 min, and a final extension 
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step at 72°C for 10 min. PCR products of the expected size were purified using the 
NucleoSpin® Gel kit (Macherey Nagel) after gel electrophoresis. 3'-A overhangs were added 
to the purified products before being cloned into the pcDNA3.1/V5-His-TOPO vector 
(Invitrogen) in accordance with the manufacturer’s instructions. Transformation was performed 
using XL10-Gold Ultracompetent Cells (Stratagene). Transformed cells were spread onto LB 
agar plates with 50 μg/ml ampicillin and incubated at 37°C overnight. 
Plasmid constructs containing inserts in the right orientation were selected for 
simultaneously by two PCRs using the HotStarTaq Master Mix Kit (Qiagen). The first PCR 
amplifies a 235-bp fragment extending from the T7 promoter/priming site (located within the 
vector) to the exon 1/intron 1 boundary of CEL (i.e. primer pair A2 in Supplementary Table 1). 
The second PCR amplifies an approximately 1.3-kb fragment going from the beginning of CEL 
exon 10 to the BGH reverse priming site (located within the vector) (i.e. primer pair A3 in 
Supplementary Table 1). Selected plasmids were then sequenced using primer S10F (see 
Supplementary Figure 2) to pick up those carrying the desired CEL–HYB1 or CEL–HYB2a 
variant.  
 
Cell Culture, Transfection and Cycloheximide Treatment  
Human embryonic kidney (HEK) 293T cells were cultured in DMEM nutrient mixture with 
10% fetal calf serum. 3.5 x 105 cells were seeded per well of 6-well plates 24 hours prior to 
transfection. For conventional RT-PCR analyses (see below), 1 μg pcDNA3.1-CEL–HYB1 or 
pcDNA3.1-CEL–HYB2a plasmid, which were mixed with 3 μL Lipofectamine 2000 Reagent 
(Invitrogen), were used for transfection per well. For real-time quantitative RT-PCR analyses 
(see below), 500 ng pcDNA3.1-CEL–HYB1 or pcDNA3.1-CEL–HYB2a plasmid were mixed 
with 500 ng pGL3-GP2 minigene for transfection. Forty-eight hours after transfection, total 
RNA was extracted using the RNeasy Mini Kit (Qiagen). For the NMD inhibition experiment, 
50 μg/mL (final concentration) cycloheximide (Sigma) were added to the cells 4 hours before 
RNA extraction. 
 
Reverse Transcription 
Reverse transcription (RT) was performed using the SuperScript II Reverse Transcriptase 
(Life Technologies) with 1 µg total RNA, 500 µM dNTPs, 5 µM 20mer-oligo(dT) and 10 mM 
DTT (Eurogentec). The resulting cDNAs were treated with 2U RNAseH (Life Technologies) 
to degrade the remaining RNA. 
 
Conventional RT-PCR and Sequencing of the Resulting Products 
Conventional RT-PCR was performed in a 25-μl reaction mixture containing 0.5 U KAPA 
HiFi HotStart DNA Polymerase (Kapa Biosystems), 1 μl cDNA and 0.3 µM each primer of 
primer pair A4 (Supplementary Table 1). Note that this primer pair was designed to amplify a 
full-length CEL–HYB1 or CEL–HYB2a transcript. The PCR program comprised an initial 
denaturation step at 95°C for 5 min, followed by 30 cycles of denaturation at 98°C for 20 s, 
annealing at 72°C for 15 s, and extension at 72°C for 3 min, and a final extension step at 72°C 
for 5 min. 
RT-PCR products were cleaned using ExoSAP-IT® before being sequenced with five 
primers (Supplementary Table 2) by means of the BigDye Terminator v1.1 Cycle Sequencing 
Kit (Life Technologies). 
 
Real-Time Quantitative RT-PCR 
Real-time quantitative RT-PCR analyses were performed essentially as described 
elsewhere.16 In brief, pcDNA3.1-CEL–HYB1 or pcDNA3.1-CEL–HYB2a was co-transfected 
with the previously constructed pGL3-GP2 minigene.16 The target and reference genes were 
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PCR amplified separately; target gene expression was determined using pGL3-GP2 minigene 
expression as a reference by means of the ∆∆Ct method in accordance with the Pfaffl efficiency-
corrected calculation model.18 Real-time quantitative RT-PCR was performed in a 25μL 
mixture containing 12.5 μL HotStarTaq Master Mix Kit (Qiagen), 1 μL 1:25 diluted cDNA, 0.5 
µM SYTO9 (Life Technologies) and 0.3 μM each primer (primer pair A5 was employed for 
both CEL–HYB1 and CEL–HYB2a whilst primer pair A6 was used for the reference gene; 
Supplementary Table 1). The PCR program comprised an initial denaturation step at 95°C for 
15 min, followed by 40 cycles of denaturation at 94°C for 45 s, annealing at 55°C for 30 s and 
extension at 72°C for 30 s. Quantitative analysis of each RT-PCR amplification was performed 
in triplicate on a Lightcycler 480II (Roche, Paris, France) using “relative quantification” and 
“2nd derivative maxima” options.  
The difference between the expression levels of CEL–HYB1 and CEL–HYB2a (results 
from six independent transfection experiments) and that between expression levels of CEL–
HYB2a with and without cycloheximide treatment (results from three independent transfection 
experiments) were assessed for significance by the Student’s t-test. The difference was regarded 
as being statistically significant when the P value was ≤ 0.05.  
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Supplementary Figure Legends 
 
Supplementary Figure 1. Comparison of the originally reported PCR assay (A) and the 
currently used PCR assay (B) for detecting the CEL–HYB1 (as well as the CEL–HYB2b) allele 
(3.2 kb) in French heterozygotes. WT, wild-type (4.2 kb). NC, negative control. 
Supplementary Figure 2. Alignment of reference CEL and CELP sequences in the context of 
exon 10 (in bold) and partial flanking sequences. The crossover region for the CEL–HYB 
deletion allele9 (termed here CEL–HYB1) is doubly underlined whereas that for CEL–HYB2 
is singly underlined. The discriminant positions between the two paralogous sequences are 
indicated by numbered upwardly pointing arrows. The CEL–HYB2a variant harbors the G 
allele of rs10901232A/G, the T allele of rs10901233C/T and the G allele of rs671412A/G 
whereas the CEL–HYB2b variant harbors the alternative alleles of these three SNPs (the three 
affected sites are indicated by circles). The premature translation termination codon in the 
chimeric exon 10 of the CEL–HYB2b variant is indicated by a box. The two primers used for 
sequencing the breakpoint junctions of the CEL–HYB alleles, S10F and S10R,9 are indicated 
by horizontal dotted arrows. The CEL and CELP sequences shown in the Figure correspond to 
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nucleotide positions 12883-13599 and 28652-29371, respectively, from GenBank accession 
number AF072711.1.  
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Supplementary Table 1. PCR primer pairs used in this study 
Primer 
pair Sequence (5' > 3') Location Amplified sequence 
Amplicon size 
(bp) 
A1 
Forward: TCCATAAATACCCGAGGCCC 5'-untranslated region of CEL Full-length genomic 
CEL–HYB sequences 
9676 (HYB1) 
9678 (HYB2a) Reverse: CTTCCTGCAGCTTAGCCTTG 3'-untranslated region of CELP 
A2 
Forward: TAATACGACTCACTATAGGG T7 promoter/priming site 5' extremity of the 
constructs 235 Reverse: CTCTGCTGGGCTCTTACCTT Exon 1/intron 1 boundary of genomic CEL  
A3 
Forward: CAAGACCTACGCCTACCTGT Exon 10 of genomic CEL 3' extremity of the 
constructs 
1334 (HYB1) 
1336 (HYB2a) Reverse: TAGAAGGCACAGTCGAGG BGH reverse priming site 
A4 
Forward: GGAGACCCAAGCTGGCTAGT pcDNA3.1/5'-untranslated region Full length CEL–HYB 
transcripts 
2159 (HYB1) 
2161 (HYB2a) Reverse: CCCTCTCGGCCTCTTGAG  Between the stop codon and polyadenylation signal of CELP 
A5 
Forward: GGAGACCCAAGCTGGCTAGT pcDNA3.1/5'-untranslated region 5' extremity of CEL–
HYB cDNA 280 Reverse: ATGTCCACAGAGTCACCCAG Exon 2 of CEL 
A6a 
Forward: ACTGTTGGTAAAGCCACCAT pGL3-control/5'-untranslated region 
Exons 8 and 9 of GP2 479 
Reverse: TGTATCTTATCATGTCTGCTCGAA pGL3-control/3'-untranslated region 
a
 Primer sequences were taken from ref. 16. 
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Supplementary Table 2. Primers used for sequencing the full-length CEL–HYB1 and 
CEL–HYB2a transcripts 
Primer Sequence (5' > 3') Location 
1 GGAGACCCAAGCTGGCTAGT pcDNA3.1/5'-untranslated region 
2 GGACCTGCCCGTTATGATCT Exon 4 of CEL 
3 TGGCTGAGAAGGTGGGTTG Exon 7 of CEL 
4 CAAGACCTACGCCTACCTGT Exon 10 of CEL 
5 CCCTCTCGGCCTCTTGAG Between the stop codon and polyadenylation signal of CELP 
 
 
 
